Who owns PRELUDE THERAPEUTICS INC?
- Ticker: PRLD
- CUSIP Number: 74065p101
Tip: Access positions for across all investors
Analyze quarterly positions in Prelude Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Prelude Therapeutics stock
Who bought or sold PRELUDE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 11M | $23M | 0% | Sep 2024 |
|
| Baker Bros. Advisors | 10M | $21M | 0% | Sep 2024 |
|
| Deerfield Management Company | 3.8M | $7.8M | -9% | Sep 2024 |
|
| Boxer Capital | 1.7M | $3.5M | -33% | Sep 2024 |
|
| T. Rowe Price Associates | 1.1M | $2.3M | 23% | Sep 2024 |
|
| BlackRock | 1.1M | $4.1M | -3% | Jun 2024 |
|
| BlackRock | 1.1M | $2.2M | 100% | Sep 2024 |
|
| Vanguard Group | 1.0M | $3.9M | -1% | Jun 2024 |
|
| ExodusPoint Capital Management | 922k | $1.9M | 100% | Sep 2024 |
|
| Avidity Partners Management | 890k | $1.8M | 100% | Sep 2024 |
|
| Massachusetts Financial Services | 550k | $1.1M | 5% | Sep 2024 |
|
| Geode Capital Management | 392k | $811k | 8% | Sep 2024 |
|
| Marshall Wace | 359k | $743k | 100% | Sep 2024 |
|
| Sio Capital Management | 320k | $1.2M | 0% | Jun 2024 |
|
| Morgan Stanley | 287k | $1.1M | -3% | Jun 2024 |
|
| T. Rowe Price Investment Management | 282k | $583k | 100% | Sep 2024 |
|
| State Street Corporation | 212k | $807k | 0% | Jun 2024 |
|
| Renaissance Technologies | 197k | $408k | -5% | Sep 2024 |
|
| Jacobs Levy Equity Management | 175k | $362k | 885% | Sep 2024 |
|
| TD Asset Management | 161k | $341k | 0% | Sep 2024 |
|
| Charles Schwab Investment Management | 133k | $276k | 4% | Sep 2024 |
|
| Bridgeway Capital Management | 124k | $471k | 0% | Jun 2024 |
|
| Northern Trust | 106k | $220k | -13% | Sep 2024 |
|
| Goldman Sachs Group | 75k | $286k | 11% | Jun 2024 |
|
| Acadian Asset Management | 74k | $152k | 235% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 70k | $267k | -3% | Jun 2024 |
|
| Exchange Traded Concepts | 64k | $133k | 32% | Sep 2024 |
|
| Two Sigma Advisers | 51k | $194k | -27% | Jun 2024 |
|
| Two Sigma Investments | 43k | $164k | -29% | Jun 2024 |
|
| Cubist Systematic Strategies | 40k | $83k | 100% | Sep 2024 |
|
| Kennedy Capital Management | 35k | $134k | 41% | Jun 2024 |
|
| HPM Partners | 33k | $68k | 100% | Sep 2024 |
|
| Dimensional Fund Advisors | 29k | $60k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 29k | $59k | -21% | Sep 2024 |
|
| Barclays | 27k | $57k | 86% | Sep 2024 |
|
| Bank of America Corporation | 25k | $52k | -27% | Sep 2024 |
|
| Hsbc Holdings | 25k | $91k | 0% | Jun 2024 |
|
| Sherbrooke Park Advisers | 20k | $42k | 100% | Sep 2024 |
|
| Connor, Clark & Lunn Investment Management | 17k | $36k | 40% | Sep 2024 |
|
| Nuveen Asset Management | 17k | $64k | 0% | Jun 2024 |
|
| Citadel Advisors | 16k | $33k | -50% | Sep 2024 |
|
| Jump Financial | 16k | $32k | 100% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 15k | $30k | 0% | Sep 2024 |
|
| Rhumbline Advisers | 12k | $25k | -44% | Sep 2024 |
|
| Jane Street | 10k | $21k | -20% | Sep 2024 |
|
| Citigroup | 9.7k | $20k | 220% | Sep 2024 |
|
| Simplex Trading | 9.3k | $19k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 7.3k | $15k | -11% | Sep 2024 |
|
| Tower Research Capital | 7.1k | $27k | 111% | Jun 2024 |
|
| Wells Fargo & Company | 6.1k | $13k | 5% | Sep 2024 |
|
| Jpmorgan Chase & Co | 6.0k | $12k | 2% | Sep 2024 |
|
| Point72 | 5.2k | $11k | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 3.6k | $7.0k | -81% | Sep 2024 |
|
| Qube Research & Technologies | 3.1k | $12k | 100% | Jun 2024 |
|
| Royal Bank of Canada | 2.9k | $6.7k | -3% | Sep 2024 |
|
| Russell Investments | 1.5k | $5.6k | 100% | Jun 2024 |
|
| California State Teachers Retirement System | 955.00 | $2.0k | 0% | Sep 2024 |
|
| Summit Investment Advisors | 819.00 | $1.7k | 0% | Sep 2024 |
|
| Group One Trading | 500.00 | $1.0k | 100% | Sep 2024 |
|
| Amalgamated Bank | 334.00 | $999.996000 | 0% | Sep 2024 |
|
| Pnc Financial Services | 64.00 | $132.000000 | 0% | Sep 2024 |
|
| HighMark Wealth Management | 50.00 | $104.000000 | 0% | Sep 2024 |
|
| Sterling Capital Management | 42.00 | $86.998800 | 100% | Sep 2024 |
|
| SRS Capital Advisors | 19.00 | $40.000700 | 0% | Sep 2024 |
|
| CWM | 10.00 | $0 | -55% | Sep 2024 |
|
| Capital Performance Advisors | 8.00 | $17.000000 | 100% | Sep 2024 |
|
Who sold out of Prelude Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Y-Intercept | Jun 2024 | 19k | $72k |
| Amundi | Mar 2024 | 15k | $52k |
| NISA Investment Advisors | Jun 2024 | 2.1k | $8.0k |